Navigation Links
Cytopia Announces Novel Anti-Cancer Drug Development Collaboration
Date:5/9/2008

cancer drugs from Australia's research base. It will undertake responsibility for the further development of Cytopia's early compounds towards a preclinical candidate compound which is capable of further development into and through clinical trials.

"We are delighted to be embarking on a collaboration of this type with a leading Australian drug development company such as Cytopia," said Tony Evans, CEO of Cancer Therapeutics. "Our company was founded with the vision to aid in the further development of Australian biotechnology industry by applying drug discovery and development capabilities to early research findings and take on projects that are in the high risk category from commercial organizations or academic institutions to unlock their commercial potential."

Cytopia's advanced anti-cancer drug is being tested in four clinical programs covering oral and IV doses in Phase I and Phase II level studies. Trials are advanced for both oral and injectable vascular disrupting agents (VDAs), multiple myeloma and an aggressive brain tumor glioblastoma multiforme (GBM).

About Cytopia

Cytopia Ltd is an Australian biotechnology company focused on the discovery and development of new drugs to treat cancer and other diseases. Cytopia conducts its research and development via subsidiaries based in Melbourne, Australia and New York and specializes in discovering new molecules with an improved therapeutic profile for the treatment of cancer. Cytopia's lead compound, CYT997, is currently in Phase II clinical trials.

Website: http://www.cytopia.com.au

About Cancer Therapeutics

Cancer Therapeutics CRC Pty Ltd has been formed through a collaboration between a number of Australia's leading research institutions and commercial organizations for the purposes of cancer drug discovery and development. It is funded under the Australian Government's CRC scheme. The objective of the Compa
'/>"/>

SOURCE Cytopia Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Touro College has announced that it is supporting ... media marijuana licenses to be issued by the ... If CanniCare is selected, Touro would provide the ... college is supportive of medicinal development and research," said ... "There is still a great deal of research to be ...
(Date:7/29/2015)...  Henry Schein, Inc. (NASDAQ: HSIC ), ... and services to office-based dental, animal health and ... results. Net sales for the quarter ... increase of 0.5% compared with the second quarter ... local currencies and a 7.0% decline related to ...
(Date:7/29/2015)... CITY, Calif. , July 29, 2015 /PRNewswire/ ... specialty pharmaceutical company focused on the development and ... acute and breakthrough pain, today announced that it ... close on Monday, Aug 3rd, 2015. AcelRx management ... p.m. Eastern Time (1:30 p.m. Pacific Time) on ...
Breaking Medicine Technology:Touro College Announces Support for CanniCare's Medical Cannabis License Application 2Henry Schein Reports Record Second Quarter Results 2Henry Schein Reports Record Second Quarter Results 3Henry Schein Reports Record Second Quarter Results 4Henry Schein Reports Record Second Quarter Results 5Henry Schein Reports Record Second Quarter Results 6Henry Schein Reports Record Second Quarter Results 7Henry Schein Reports Record Second Quarter Results 8Henry Schein Reports Record Second Quarter Results 9Henry Schein Reports Record Second Quarter Results 10Henry Schein Reports Record Second Quarter Results 11Henry Schein Reports Record Second Quarter Results 12Henry Schein Reports Record Second Quarter Results 13Henry Schein Reports Record Second Quarter Results 14Henry Schein Reports Record Second Quarter Results 15Henry Schein Reports Record Second Quarter Results 16Henry Schein Reports Record Second Quarter Results 17Henry Schein Reports Record Second Quarter Results 18Henry Schein Reports Record Second Quarter Results 19Henry Schein Reports Record Second Quarter Results 20Henry Schein Reports Record Second Quarter Results 21Henry Schein Reports Record Second Quarter Results 22Henry Schein Reports Record Second Quarter Results 23Henry Schein Reports Record Second Quarter Results 24Henry Schein Reports Record Second Quarter Results 25AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 3AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 4
(Date:7/29/2015)... ... 2015 , ... Toronto native Douglas James Cottrell, Ph.D., has ... been making predictions about the economy, politics, social issues, as well as the ... warns that extreme weather conditions and increased earthquake / volcanic activity will increase ...
(Date:7/29/2015)... ... 29, 2015 , ... " mybody ” was featured on NewsWatch as part ... businesses making an impact in their industry. Andrew Tropeano, the host of NewsWatch and ... skincare products are designed to strengthen the skin’s defense system from the inside out. ...
(Date:7/29/2015)... ... July 29, 2015 , ... National ... provider of life insurance, annuities, employee benefits and asset management, has joined as ... sporting event taking place in Charlotte, North Carolina on October 2-4, 2015. , ...
(Date:7/29/2015)... , ... July 29, 2015 , ... People that are ... two new products on Mercola.com: a vertical “garden tower” and enhanced mineral product for ... squeezed into small corners on a porch, balcony, or rooftop – can hold up ...
(Date:7/29/2015)... DC (PRWEB) , ... July 29, 2015 , ... ... aluminum-related illnesses is seeking funding for a study on the potentially lifesaving impact ... Research Institute today . , The research proposal is based on a ...
Breaking Medicine News(10 mins):Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3
... to researchers, chemotherapy brings about long lasting modifications in ... responsible// for the mental fog and confusion in several ... researchers at the University of California, Los Angeles, revealed ... cortex in women who had undergone chemotherapy 5-10 years ...
... from over in Bihar with the detection of new cases ... immunisation drive this year//. ,Eight districts of Magadh and ... cases were detected in Jehanand, while one each came up ... new cases of polio, an official said. ,Keeping the ...
... daily physical exercise for their future good health, says a ... children at 36 nurseries in Glasgow. ,The researchers ... exercise - 30 minutes, three times a week, reported the ... was not enough to affect the children's body mass index ...
... experts, some cancer patients are experiencing unjust dismissal and ... legislation to protect their rights//. ,The Disability ... last year has provided effective protection at work to ... the Disability Rights Commission (DRC) has reported that 200 ...
... has received a shot in the arm by way of ... have found that Aspirin is endowed with the potential to ... the bud. Indeed, this information may throw open a plethora ... Dr Helen Arthur of Newcastle University, previous research has indicated ...
... patients with schizophrenia whose medication is changed because ... drugs do not appear to offer significant benefits ... report in the October issue of Archives of ... ,The findings run contrary to the widely ...
Cached Medicine News:Health News:Chemotherapy causes mental fog 2Health News:Injustice to cancer patients at work 2Health News:New Antipsychotic Medications have Little Advantage Over Older Drugs 2Health News:New Antipsychotic Medications have Little Advantage Over Older Drugs 3
Shandon Paraffin Block Cartons...
... histological embedment block cataloging ... file system incorporates the ... block protection, simplified cataloging, ... and facilitation of retrieval. ...
The Modular Storage Drawers provide permanent storage and identification of up to 165 embedding rings or 250 cassettes per drawer....
... The first instrumentation ... efficiently manage the ... Proven technology automatically ... collates cassettes sequentially. ...
Medicine Products: